Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Gallegos

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Computational Chemistry|February 27, 2009
Notes on quantitative structure-properties relationships (QSPR) part 2: the role of the number of atoms as a molecular descriptorRamon Carbó-Dorca, Ana Gallegos Saliner
The Journal of Physical Chemistry. A|July 13, 2006
Multicenter bond indices as a new means for the quantitative characterization of homoaromaticityRobert Ponec, Patrick Bultinck, Ana Gallegos Saliner
Addiction (Abingdon, England)|July 28, 2010
How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case studyPaul Griffiths, Roumen Sedefov, Ana Gallegos, et al.
Idrugs : the Investigational Drugs Journal|October 2, 2008
Toward in silico approaches for investigating the activity of nanoparticles in therapeutic developmentAna Gallegos Saliner, Albert Poater, Andrew P Worth
Journal of Computational Chemistry|October 24, 2008
Notes on quantitative structure-properties relationships (QSPR) (1): A discussion on a QSPR dimensionality paradox (QSPR DP) and its quantum resolutionRamon Carbó-Dorca, Ana Gallegos, Angel J Sánchez
Addiction (Abingdon, England)|July 17, 2025
Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids-Is Europe prepared? Time to respond and to learnIsabelle Giraudon, Ana Gallegos, Senad Handanagić, et al.
Drug Testing and Analysis|November 8, 2022
EMCDDA framework and practical guidance for naming synthetic cannabinoidsBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|February 23, 2024
EMCDDA framework and practical guidance for naming cathinonesBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|December 12, 2022
From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present dayRachael Andrews, Rita Jorge, Rachel Christie, et al.
Forensic Science International|February 4, 2026
Semi-synthetic cannabinoids: Recent developments, analytical challenges and strategic responsesRachel Christie, Ross Conlon, Thomas Néfau, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Computational Chemistry|February 27, 2009
Notes on quantitative structure-properties relationships (QSPR) part 2: the role of the number of atoms as a molecular descriptorRamon Carbó-Dorca, Ana Gallegos Saliner
The Journal of Physical Chemistry. A|July 13, 2006
Multicenter bond indices as a new means for the quantitative characterization of homoaromaticityRobert Ponec, Patrick Bultinck, Ana Gallegos Saliner
Addiction (Abingdon, England)|July 28, 2010
How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case studyPaul Griffiths, Roumen Sedefov, Ana Gallegos, et al.
Idrugs : the Investigational Drugs Journal|October 2, 2008
Toward in silico approaches for investigating the activity of nanoparticles in therapeutic developmentAna Gallegos Saliner, Albert Poater, Andrew P Worth
Journal of Computational Chemistry|October 24, 2008
Notes on quantitative structure-properties relationships (QSPR) (1): A discussion on a QSPR dimensionality paradox (QSPR DP) and its quantum resolutionRamon Carbó-Dorca, Ana Gallegos, Angel J Sánchez
Addiction (Abingdon, England)|July 17, 2025
Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids-Is Europe prepared? Time to respond and to learnIsabelle Giraudon, Ana Gallegos, Senad Handanagić, et al.
Drug Testing and Analysis|November 8, 2022
EMCDDA framework and practical guidance for naming synthetic cannabinoidsBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|February 23, 2024
EMCDDA framework and practical guidance for naming cathinonesBenedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis|December 12, 2022
From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present dayRachael Andrews, Rita Jorge, Rachel Christie, et al.
Forensic Science International|February 4, 2026
Semi-synthetic cannabinoids: Recent developments, analytical challenges and strategic responsesRachel Christie, Ross Conlon, Thomas Néfau, et al.
Pageof 3